miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells

International Journal of Oncology
Nobuhiko NishijimaAkihiko Gemma

Abstract

Nintedanib (BIBF1120) is a multi-targeted angiokinase inhibitor and has been evaluated in idiopathic pulmonary fibrosis and advanced non-small cell lung cancer (NSCLC) patients in clinical studies. In the present study, we evaluated the antitumor effects of nintedanib in 16 NSCLC cell lines and tried to identify microRNA (miRNA) associated with sensitivity to nintedanib. No correlations between FGFR, PDGFR and VEGFR family activation and sensitivity to nintedanib were found. The difference in miRNA expression profiles between 5 nintedanib-sensitive and 5 nintedanib-resistant cell lines was evaluated by miRNA array and quantitative RT-PCR analysis (qRT-PCR). Expression of miR-200b, miR-200a and miR-141 belonging to the miR-200 family which contributes to epithelial-mesenchymal transition (EMT), was significantly lower in 5 nintedanib-resistant than in 5 nintedanib-sensitive cell lines. We examined the protein expression of EMT markers in these 10 NSCLC cell lines. E-cadherin expression was lower, and vimentin and ZEB1 expression were higher in 5 nintedanib-resistant cell lines. PC-1 was the most sensitive of the NSCLC cell lines to nintedanib. We established nintedanib-resistant PC-1 cells (PC-1R) by the stepwise method. PC-1R c...Continue Reading

References

Mar 16, 2005·Cell·Steven M JohnsonFrank J Slack
Jun 10, 2005·Nature·Jun LuTodd R Golub
Dec 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert L YauchLukas C Amler
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefano VoliniaCarlo M Croce
Mar 15, 2006·Cancer Cell·Nozomu YanaiharaCurtis C Harris
Aug 10, 2007·Journal of the National Cancer Institute·Masahiro SeikeCurtis C Harris
Jul 15, 2009·Proceedings of the National Academy of Sciences of the United States of America·Masahiro SeikeCurtis C Harris
May 25, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yuji MinegishiAkihiko Gemma
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
May 21, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Kenichi SudaTetsuya Mitsudomi
Oct 14, 2011·The New England Journal of Medicine·Luca RicheldiRoland M du Bois
Dec 23, 2011·The American Journal of Pathology·Shanzhong YangGang Liu
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
May 20, 2014·The New England Journal of Medicine·Luca RicheldiUNKNOWN INPULSIS Trial Investigators

❮ Previous
Next ❯

Citations

Nov 22, 2016·Expert Opinion on Drug Discovery·Jing XueXiaoming Liu
Feb 17, 2019·Journal of Cellular Physiology·Fan YangYongmei Yin
May 27, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Eva KaramitopoulouErik Vassella
Jun 27, 2019·International Journal of Immunopathology and Pharmacology·Shuquan WeiZiwen Zhao
Nov 13, 2016·Biomolecular Concepts·Daniel SenfterRobert M Mader
Jul 6, 2017·Free Radical Research·Yi-Hsuan WuDaniel Tsun-Yee Chiu
Mar 1, 2019·Cancers·Shang-Gin WuJin-Yuan Shih
Sep 14, 2018·Frontiers in Oncology·Fabio CorràStefano Volinia
Nov 7, 2017·Experimental and Therapeutic Medicine·Lin AngZheng-Sheng Wu
Jul 28, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Bowen Du, Joong Sup Shim
Jan 29, 2021·Cancer Communications·Guangtao PanShenglan Yang
Apr 4, 2020·Molecular Metabolism·Aarif Siddiqui, Paolo Ceppi
Feb 27, 2021·Chemical Communications : Chem Comm·Xiong ChenJinlan Zhang
Dec 1, 2020·Translational Research : the Journal of Laboratory and Clinical Medicine·Shen ZhongJürgen Borlak
May 2, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Longqiu YangXuejie Fei

❮ Previous
Next ❯

Methods Mentioned

BETA
chips
PCR
transfection
xenografts

Software Mentioned

[UNK]

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.